08/18/14 - 07:47 AM EDT
Spectrum's Beleodaq for Non-Hodgkin's lymphoma received FDA approval on July 3, but the stock then fell 26%. The same thing won't happen with Melphalan because sales numbers are already established.
07/31/14 - 02:48 PM EDT
Toyota is scrapping its electric vehicle line to go into fuel cells. Is this a step backwards? Not really.
06/02/14 - 01:26 PM EDT
Vertex Pharmaceuticals is now within weeks, or even days, of announcing top-line results on its two phase 3 cystic fibrosis studies. The science, phase 2 data, and FDA approval history for cystic fibrosis all suggest that Vertex is about to explode higher.